Blog

Tau Immunotherapy Shows Great Potential in Pre-Clinical Studies – PR Newswire (press release)

Tau Immunotherapy Shows Great Potential in Pre-Clinical Studies
PR Newswire (press release)
Anti-Aβ immunotherapy is considered one of the most promising AD treatments under investigation, and is currently being tested in many clinical trials. Unfortunately, none of the attempts reported to date have shown a positive clinical outcome in

2017-05-08 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.